373 related articles for article (PubMed ID: 18783531)
21. Testosterone for low libido in postmenopausal women not taking estrogen.
Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
[TBL] [Abstract][Full Text] [Related]
22. Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial.
Tuiten A; Michiels F; Böcker KB; Höhle D; van Honk J; de Lange RP; van Rooij K; Kessels R; Bloemers J; Gerritsen J; Janssen P; de Leede L; Meyer JJ; Everaerd W; Frijlink HW; Koppeschaar HP; Olivier B; Pfaus JG
Womens Health (Lond); 2018; 14():1745506518788970. PubMed ID: 30016917
[TBL] [Abstract][Full Text] [Related]
23. The clinical use of androgens in female sexual disorders.
Davis SR
J Sex Marital Ther; 1998; 24(3):153-63. PubMed ID: 9670121
[TBL] [Abstract][Full Text] [Related]
24. Androgen treatment of postmenopausal women.
Davis SR; Worsley R
J Steroid Biochem Mol Biol; 2014 Jul; 142():107-14. PubMed ID: 23727129
[TBL] [Abstract][Full Text] [Related]
25. Approved hormonal treatments for HSDD: an unmet medical need.
Snabes MC; Simes SM
J Sex Med; 2009 Jul; 6(7):1846-9. PubMed ID: 19453872
[TBL] [Abstract][Full Text] [Related]
26. Treating low sexual desire - new findings for testosterone in women.
Heiman JR
N Engl J Med; 2008 Nov; 359(19):2047-9. PubMed ID: 18987373
[No Abstract] [Full Text] [Related]
27. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Davis SR; Braunstein GD
J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
[TBL] [Abstract][Full Text] [Related]
28. Role of testosterone in the treatment of hypoactive sexual desire disorder.
Schwenkhagen A; Studd J
Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
[TBL] [Abstract][Full Text] [Related]
29. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).
Leiblum SR; Koochaki PE; Rodenberg CA; Barton IP; Rosen RC
Menopause; 2006; 13(1):46-56. PubMed ID: 16607098
[TBL] [Abstract][Full Text] [Related]
30. Endocrine aspects of female sexual dysfunction.
Davis SR; Guay AT; Shifren JL; Mazer NA
J Sex Med; 2004 Jul; 1(1):82-6. PubMed ID: 16422987
[TBL] [Abstract][Full Text] [Related]
31. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
[TBL] [Abstract][Full Text] [Related]
32. Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
Davis SR; Baber R; Panay N; Bitzer J; Perez SC; Islam RM; Kaunitz AM; Kingsberg SA; Lambrinoudaki I; Liu J; Parish SJ; Pinkerton J; Rymer J; Simon JA; Vignozzi L; Wierman ME
J Clin Endocrinol Metab; 2019 Oct; 104(10):4660-4666. PubMed ID: 31498871
[TBL] [Abstract][Full Text] [Related]
33. Hormonal factors in female sexual dysfunction.
Anastasiadis AG; Davis AR; Salomon L; Burchardt M; Shabsigh R
Curr Opin Urol; 2002 Nov; 12(6):503-7. PubMed ID: 12409881
[TBL] [Abstract][Full Text] [Related]
34. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.
Abdallah RT; Simon JA
Int J Impot Res; 2007; 19(5):458-63. PubMed ID: 17581596
[TBL] [Abstract][Full Text] [Related]
35. Study identifies effective testosterone dose for women.
Harv Womens Health Watch; 2014 Nov; 22(3):8. PubMed ID: 26080465
[No Abstract] [Full Text] [Related]
36. Androgen therapy in women, beyond libido.
Davis SR
Climacteric; 2013 Aug; 16 Suppl 1():18-24. PubMed ID: 23647457
[TBL] [Abstract][Full Text] [Related]
37. Testosterone therapy and other treatment modalities for female sexual dysfunction.
Ingram CF; Payne KS; Messore M; Scovell JM
Curr Opin Urol; 2020 May; 30(3):309-316. PubMed ID: 32205812
[TBL] [Abstract][Full Text] [Related]
38. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
39. Menopause and sexual desire: the role of testosterone.
Nappi RE; Albani F; Santamaria V; Tonani S; Martini E; Terreno E; Brambilla E; Polatti F
Menopause Int; 2010 Dec; 16(4):162-8. PubMed ID: 21156854
[TBL] [Abstract][Full Text] [Related]
40. Patient Handout. What you should know about testosterone for midlife women with sexual problems.
Menopause; 2013 Jul; 20(7):e1. PubMed ID: 23632654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
